ROMIO, LORIC, and Beyond: Key Ortho-K Clinical Studies

Article Title: ROMIO, LORIC, and Beyond: Key Ortho-K Clinical Studies

ARTICLE: As an optometrist who has dedicated my career to fighting childhood myopia, I’ve had countless conversations with concerned parents. Here in Fayetteville, with so many of our neighbors serving at Fort Liberty, I often hear the same questions: “our clinical team, how do we know this works? What’s the proof?” It’s a fair question. When it comes to your child’s health, you deserve more than just promises; you deserve evidence.

That’s why I want to pull back the curtain and talk about the science behind sleepSEE® Ortho-K. This isn’t a new fad. It’s a well-established, non-surgical method for myopia control, backed by decades of rigorous scientific research. We’re going to walk through the landmark clinical studies that have shown, time and again, that orthokeratology is a safe and effective way to slow down the progression of nearsightedness in children. We’ll look at the data, what it means, and why it gives us confidence in recommending this treatment for families across Cumberland County.

Table of Contents

• The Foundation: LORIC and ROMIO Studies
• Expanding the Evidence: SMART and TO-SEE
• What Does This All Mean for your child?
• Ortho-K Clinical Studies: A Comparison
• Frequently Asked Questions

The Foundation: LORIC and ROMIO Studies

To really understand the confidence we have in ortho-k, we have to start with two groundbreaking studies that laid the foundation for everything we know today: the LORIC and ROMIO studies. These were among the first to rigorously test the idea that ortho-k could do more than just temporarily correct vision—it could actually control myopia.

The LORIC Study (2005): A Pioneering Pilot

The Longitudinal Orthokeratology Research in Children (LORIC) study, published in 2005, was a true pioneer. [1] It was a two-year pilot study that set out to answer a simple question: does ortho-k slow down the elongation of the eye in myopic children? The eye’s axial length—the distance from the front to the back of the eye—is the most critical measurement in myopia control. A longer eye means higher myopia. The LORIC researchers followed 35 children wearing ortho-k lenses and compared their eye growth to a control group of 35 children wearing standard single-vision glasses.

The results were a watershed moment. Over two years, the children wearing ortho-k lenses showed an average axial elongation of just 0.29 mm, compared to 0.54 mm in the glasses-wearing group. That’s a nearly 46% reduction in eye growth! LORIC provided the first strong, data-driven evidence that ortho-k was a powerful tool for myopia control.

The ROMIO Study (2012): Randomized and Controlled

Building on LORIC’s success, the Retardation of Myopia in Orthokeratology (ROMIO) study, published in 2012, took the research to the next level. [2] This was a larger, single-masked, randomized clinical trial—the gold standard in medical research. They recruited 102 children between the ages of 6 and 10 and randomly assigned them to either wear ortho-k lenses or single-vision glasses for two years.

The findings were even more definitive. The ortho-k group’s eyes grew by an average of 0.36 mm, while the control group’s eyes grew by 0.63 mm. This represented a 43% slowing of myopia progression. The ROMIO study also revealed another crucial insight: the treatment was most effective in younger children (ages 7-8), who tend to have the fastest rates of myopia progression. This highlighted the importance of starting myopia management early, a principle we emphasize to parents right here in our Fayetteville clinic.

*A key part of these studies is the precise measurement of axial length using a biometer. This allows us to track the physical growth of the eye, which is the true measure of myopia progression.*

Expanding the Evidence: SMART and TO-SEE

The compelling results from LORIC and ROMIO sparked a wave of further research. Scientists wanted to confirm the findings in different populations and with different types of astigmatism. Two of the most important follow-up studies were the SMART and TO-SEE studies.

The SMART Study: A Large-Scale Confirmation

The Stabilizing Myopia by Accelerating Reshaping Technology (SMART) study was a large, five-year study in the United States that further validated the effectiveness of ortho-k. [3] This multicenter prospective study provided even more real-world evidence, confirming that the results seen in the earlier, more controlled trials held true across a larger and more diverse group of patients. The SMART study solidified ortho-k’s reputation as a reliable and predictable method for myopia control.

The TO-SEE Study (2013): Tackling Astigmatism

One of the questions that remained after the initial studies was whether ortho-k could be effective for children with significant astigmatism. That’s where the Toric Orthokeratology for Slowing Eye Elongation (TO-SEE) study came in. [4] Published in 2013, this study specifically recruited 80 children with moderate-to-high levels of astigmatism.

For families in Fayetteville and Fort Liberty, where we see a wide range of prescriptions, this was a critical piece of the puzzle. The TO-SEE study showed that specially designed toric ortho-k lenses were incredibly effective. Over two years, the children wearing toric ortho-k lenses experienced 52% less axial elongation than the control group (0.31 mm vs. 0.64 mm). This proved that even children with more complex prescriptions could benefit significantly from ortho-k myopia management.

*This chart summarizes the dramatic difference in eye growth between children wearing ortho-k lenses and those in the control groups across the major studies.*

What Does This All Mean for your child?

So, we’ve looked at the data from these major studies. But what does it all mean for your family, right here in Cumberland County? It means that when we recommend sleepSEE® ortho-k, it’s not based on a hunch. It’s based on a solid foundation of scientific evidence that demonstrates three key things:

1. Ortho-K Works: Across multiple high-quality studies, ortho-k has been consistently shown to slow down the rate of axial elongation—the underlying cause of myopia progression—by approximately 40-55%.
2. It’s for (Almost) Everyone: Whether your child has a simple prescription or more complex astigmatism, there’s a good chance they are a candidate. The TO-SEE study proved that modern toric lenses can provide excellent myopia control for a wider range of children than ever before. The best way to know for sure is to take our Candidacy Quiz [blocked].
3. Early Action is Key: The ROMIO study showed us that the benefits of myopia control are most significant for younger children, whose eyes are growing the fastest. If you’re noticing your child’s vision changing, the time to act is now.

*The major ortho-k studies have involved hundreds of children over multiple years, providing a robust body of evidence for the treatment's effectiveness.*

Ortho-K Clinical Studies: A Comparison

To make it easier to see the combined weight of the evidence, here’s a table comparing the key details of the landmark studies we’ve discussed.